Jane Street’s Eucrates Biomedical Acquisition Corp. Ordinary Shares EUCR Stock Holding History

Jane Street’s Portfolio EUCR Stock Details EUCR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-108,553	Closed	-$1.09M	–	10538
2022 Q3	$1.09M	Buy	108,553 +2,386	+2%	+$23.8K	﹤0.01%	5267
2022 Q2	$1.05M	Buy	106,167 +14	+0%	+$138	﹤0.01%	5396
2022 Q1	$1.05M	Hold	106,153	–	–	﹤0.01%	6037
2021 Q4	$1.04M	Hold	106,153	–	–	﹤0.01%	5831
2021 Q3	$1.04M	Buy	106,153 +249	+0.2%	+$2.43K	﹤0.01%	5832
2021 Q2	$1.04M	Buy	105,904 +22,352	+27%	+$220K	﹤0.01%	5747
2021 Q1	$834K	Buy	+83,552	New	+$858K	﹤0.01%	5806

Other funds holding EUCR

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

SIA

SkyView Investment Advisors Shrewsbury, New Jersey $743M AUM 17.91% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Jane Street's EUCR Position: Q4 2022 in Review

Jane Street sold out of Eucrates Biomedical Acquisition Corp. Ordinary Shares (EUCR) in Q4 2022, closing a stake of 108,553 shares — an estimated $1.09M sold.

Jane Street first reported a position in EUCR in Q1 2021 and held it in 7 quarters. The position peaked at $1.09M in Q3 2022. 5 funds tracked by Wall St. Rank hold EUCR as of Q4 2022.

Jane Street reported no remaining Eucrates Biomedical Acquisition Corp. Ordinary Shares position as of Q4 2022 after selling out during the quarter.
Jane Street sold 108,553 Eucrates Biomedical Acquisition Corp. Ordinary Shares shares in Q4 2022, an estimated $1.09M.
Jane Street first reported a position in Eucrates Biomedical Acquisition Corp. Ordinary Shares in Q1 2021 and held it in 7 quarters.
Jane Street's Eucrates Biomedical Acquisition Corp. Ordinary Shares position peaked at $1.09M in Q3 2022.
5 funds tracked by Wall St. Rank held Eucrates Biomedical Acquisition Corp. Ordinary Shares as of Q4 2022.

Based on Jane Street's 13F filing for Q4 2022, filed 15 Feb 2023.